AlzeCure Pharma AB (FRA:AC6) Pretax Margin %: % (As of Mar. 2026)

What is AlzeCure Pharma AB Pretax Margin %?

AlzeCure Pharma AB FRA:AC6 -6.97% 33 Pretax Margin % is % as of Mar. 2026. GuruFocus rates FRA:AC6 with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 941 Biotechnology companies, AlzeCure Pharma AB ranks worse than 106269.82% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. AlzeCure Pharma AB's Pre-Tax Income for the three months ended in Mar. 2026 was €-2.01 Mil. AlzeCure Pharma AB's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, AlzeCure Pharma AB's pretax margin for the quarter that ended in Mar. 2026 was %.

The historical rank and industry rank for AlzeCure Pharma AB's Pretax Margin % or its related term are showing as below:

FRA:AC6's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -89.42
* Ranked among companies with meaningful Pretax Margin % only.

AlzeCure Pharma AB (FRA:AC6) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

AlzeCure Pharma AB Pretax Margin % Related Terms

AlzeCure Pharma AB Pretax Margin % Historical Data

* Premium members only.

The historical data trend for AlzeCure Pharma AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AlzeCure Pharma AB Pretax Margin % Chart

AlzeCure Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Pretax Margin %

Get a 7-Day Free Trial

0.00

AlzeCure Pharma AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Pretax Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

FRA:AC6 vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, AlzeCure Pharma AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AlzeCure Pharma AB Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AlzeCure Pharma AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where AlzeCure Pharma AB's Pretax Margin % falls into.

Save Embed

33GF Score

AlzeCure Pharma AB FRA:AC6

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

AlzeCure Pharma AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

AlzeCure Pharma AB's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-4.381	/	0
	=	%

AlzeCure Pharma AB's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-2.014	/	0
	=	%

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of % mean?

AlzeCure Pharma AB (FRA:AC6) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on AlzeCure Pharma AB and its competitors. According to the industry distribution chart, AlzeCure Pharma AB ranks #999999 out of 941 companies in the Biotechnology industry.

Is AlzeCure Pharma AB's Pretax Margin % too high?

AlzeCure Pharma AB's current Pretax Margin % is %. Based on the distribution chart, AlzeCure Pharma AB ranks #999999 out of 941 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, AlzeCure Pharma AB has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.

How does AlzeCure Pharma AB's Pretax Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, AlzeCure Pharma AB ranks #999999 out of 941 companies for Pretax Margin %. This places AlzeCure Pharma AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on AlzeCure Pharma AB and its competitors. AlzeCure Pharma AB's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is AlzeCure Pharma AB stock overvalued right now?

AlzeCure Pharma AB (FRA:AC6) has a current Pretax Margin % of %. The current Pretax Margin % is %. AlzeCure Pharma AB's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For AlzeCure Pharma AB (FRA:AC6), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AlzeCure Pharma AB Business Description

Industry Healthcare Biotechnology

Comparable Companies OSTO:CANTA XSAT:CESSA OSTO:SPRINT OSTO:CLBIO OSTO:IVACC OSTO:ACE OSTO:ONCO OSTO:IMMU OSTO:FLUO OSTO:XSPRAY VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges ALZCUR:Sweden

Address Halsovagen 7, Huddinge, SWE, SE 141 57

Website https://www.alzecurepharma.se

AlzeCure Pharma AB is a Swedish pharmaceutical company engaged in drug research with a primary focus on Alzheimer's disease. The company develops several drugs within its three research platforms, NeuroRestore, Alzstatin, and Painless. The company's drug candidates include: ACD440, which is in the clinical development phase for the treatment of neuropathic pain, ACD856, ACD857, and ACD680 for the treatment of Alzheimer's disease, and ACD137 for the treatment of severe pain in conditions such as osteoarthritis.

33GF Score

Get the complete analysis for FRA:AC6

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.53

Price

View FRA:AC6 Analysis

See Pretax Margin % data for all stocks →